Collegium Pharmaceutical COLL
NASDAQ COLL
$22.91 -0.32 (-1.38%)
As of: Oct 21, 2026 · 3:59 PM EDT

Collegium Pharmaceutical (COLL) Non-Current Deferred Tax Liability (2026)

Updated

Collegium Pharmaceutical (COLL) reported Non-Current Deferred Tax Liability of $40.97 million for Q2 2026.

Analysis

Collegium Pharmaceutical (COLL) Non-Current Deferred Tax Liability (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Collegium Pharmaceutical 744.00 Mn -479.76 Mn 110.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.97 Mn
API Access

Collegium Pharmaceutical Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=COLL&period=max&api_key=YOUR_API_KEY